— Know what they know.
Not Investment Advice

ADMA Short Interest

ADMA Biologics, Inc.
1W: +0.0% 1M: +18.0% 3M: +25.9% YTD: -38.1% 1Y: -27.4% 3Y: +251.4% 5Y: +906.4%
$11.17
+0.10 (+0.95%)
After Hours: $10.99 (-0.18, -1.61%)
Weekly Expected Move ±5.8%
$9 $10 $11 $11 $12
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 74 · $2.5B mcap · 220M float · 1.29% daily turnover · Short 46% of daily vol
Credit Risk of going bust: lower than 57% of companies Debt: 7.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.10 (down 99.1%), ADMA Biologics, Inc. would be worth roughly what it owes.
Total debt $203.8M against a stock market value of $2.48B.
Distance to default 5.90 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $100.2M (short-term plus half of long-term), stock volatility 55.4%; Altman Z'' 7.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
50.2%
Short Ratio
of total volume
38.9%
20-Day Avg
47.8%
50-Day Avg
▲ Rising
5-Day Trend
0.4M
Short Volume
0.7M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 343,086 687,566 49.9%
NYSE 20,434 35,125 58.2%
BATS 272 2,557 10.6%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms